Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chronic Lymphocytic Leukemia (CLL) Who Have Failed at Least One Prior Fludarabine-containing Regimen
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00918450 |
|
Recruitment Status :
Withdrawn
(Sponsor has decided to not proceed with this study.)
First Posted : June 11, 2009
Last Update Posted : February 26, 2010
|
Sponsor:
Abbott
Collaborator:
Genentech, Inc.
Information provided by:
Abbott
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | December 2012 |
| Study Completion Date : | No date given |